These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24423646)

  • 1. Mice with a deletion of the major central myelin protein exhibit hypersensitivity to noxious thermal stimuli: involvement of central sensitization.
    Petit B; Giraudet F; Béchon C; Bardin L; Avan P; Boespflug-Tanguy O; Bégou M
    Neurobiol Dis; 2014 May; 65():55-68. PubMed ID: 24423646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
    Patzig J; Kusch K; Fledrich R; Eichel MA; Lüders KA; Möbius W; Sereda MW; Nave KA; Martini R; Werner HB
    Glia; 2016 Jan; 64(1):155-74. PubMed ID: 26393339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic dissection of oligodendroglial and neuronal Plp1 function in a novel mouse model of spastic paraplegia type 2.
    Lüders KA; Patzig J; Simons M; Nave KA; Werner HB
    Glia; 2017 Nov; 65(11):1762-1776. PubMed ID: 28836307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological abnormalities precede apparent histological demyelination in the central nervous system of mice overexpressing proteolipid protein.
    Tanaka H; Ikenaka K; Isa T
    J Neurosci Res; 2006 Nov; 84(6):1206-16. PubMed ID: 16917838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Truong JJ; Kerr BJ
    Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice.
    Kim CF; Moalem-Taylor G
    J Pain; 2011 Mar; 12(3):370-83. PubMed ID: 20889388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene.
    Edgar JM; McLaughlin M; Barrie JA; McCulloch MC; Garbern J; Griffiths IR
    Acta Neuropathol; 2004 Apr; 107(4):331-5. PubMed ID: 14745569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of spinal cord in a mouse model of spastic paraplegia related to abnormal axono-myelin interactions by in vivo quantitative MRI.
    Hassen WB; Bégou M; Traore A; Moussa AB; Boehm N; Ghandour MS; Renou JP; Boespflug-Tanguy O; Bonny JM
    Neuroimage; 2009 May; 46(1):1-9. PubMed ID: 19457399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts of PLP and its role in the nervous system.
    Griffiths I; Klugmann M; Anderson T; Thomson C; Vouyiouklis D; Nave KA
    Microsc Res Tech; 1998 Jun; 41(5):344-58. PubMed ID: 9672418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.
    Garbern JY; Yool DA; Moore GJ; Wilds IB; Faulk MW; Klugmann M; Nave KA; Sistermans EA; van der Knaap MS; Bird TD; Shy ME; Kamholz JA; Griffiths IR
    Brain; 2002 Mar; 125(Pt 3):551-61. PubMed ID: 11872612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial PLP1 deletion causing X-linked dominant spastic paraplegia type 2.
    Matsufuji M; Osaka H; Gotoh L; Shimbo H; Takashima S; Inoue K
    Pediatr Neurol; 2013 Dec; 49(6):477-81. PubMed ID: 24095575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant intronic splicing enhancer mutation in myelin proteolipid protein leads to progressive microglia and astrocyte activation in white and gray matter regions of the brain.
    Bachstetter AD; Webster SJ; Van Eldik LJ; Cambi F
    J Neuroinflammation; 2013 Dec; 10():146. PubMed ID: 24314267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GD3 synthase gene knockout mice exhibit thermal hyperalgesia and mechanical allodynia but decreased response to formalin-induced prolonged noxious stimulation.
    Handa Y; Ozaki N; Honda T; Furukawa K; Tomita Y; Inoue M; Furukawa K; Okada M; Sugiura Y
    Pain; 2005 Oct; 117(3):271-279. PubMed ID: 16150545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of astrocytic S100beta in behavioral hypersensitivity in rodent models of neuropathic pain.
    Tanga FY; Raghavendra V; Nutile-McMenemy N; Marks A; Deleo JA
    Neuroscience; 2006 Jul; 140(3):1003-10. PubMed ID: 16600520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2.
    de Monasterio-Schrader P; Patzig J; Möbius W; Barrette B; Wagner TL; Kusch K; Edgar JM; Brophy PJ; Werner HB
    Glia; 2013 Nov; 61(11):1832-47. PubMed ID: 24038504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoalgesia in mice lacking aquaporin-4 water channels.
    Bao F; Chen M; Zhang Y; Zhao Z
    Brain Res Bull; 2010 Nov; 83(6):298-303. PubMed ID: 20851747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective impact of Tau loss on nociceptive primary afferents and pain sensation.
    Sotiropoulos I; Lopes AT; Pinto V; Lopes S; Carlos S; Duarte-Silva S; Neves-Carvalho A; Pinto-Ribeiro F; Pinheiro S; Fernandes R; Almeida A; Sousa N; Leite-Almeida H
    Exp Neurol; 2014 Nov; 261():486-93. PubMed ID: 25079367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain.
    Imai S; Ikegami D; Yamashita A; Shimizu T; Narita M; Niikura K; Furuya M; Kobayashi Y; Miyashita K; Okutsu D; Kato A; Nakamura A; Araki A; Omi K; Nakamura M; James Okano H; Okano H; Ando T; Takeshima H; Ushijima T; Kuzumaki N; Suzuki T; Narita M
    Brain; 2013 Mar; 136(Pt 3):828-43. PubMed ID: 23364351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
    McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
    Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.